Loading...
Thumbnail Image
Item

Zotepine versus placebo for schizophrenia

Abstract
This is the protocol for a review and there is no abstract. The objectives are as follows: To review the effects of zotepine compared with placebo for people with schizophrenia or related psychoses. As secondary objectives, we propose to investigate whether people: with schizophrenia described as 'treatment resistant' differed in their response from those whose illness was not designated as such; having predominantly positive or negative symptoms of schizophrenia were more responsive to zotepine than those without this designation; and experiencing their first episode of schizophrenia differed in their response from those at a later stage of their illness.
Copyright © 2013 The Cochrane Collaboration.
Citations
Altmetric:
Date
2013
Type
Article
Subject
Drug therapy, Schizophrenia, Psychotic disorders
Citation
Dickenson, R. & Fenton, M. (2013). Zotepine versus placebo for schizophrenia. Cochrane Database of Systematic Reviews, (7), pp.CD010644.
Journal / Source Title
DOI
PMID
Publisher
Publisher’s URL
Publisher’s statement
Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Note / Copyright